Emergence of CD52-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment

International Immunology

Volumn 8, Issue 3, 1996, Pages 325-334

  Brett, Sara J ^a   Baxter, Gillian ^a   Cooper, Helen ^a   Rowan, Wendy ^a   Regan, Tessa ^a   Tite, John ^a   Rapson, Nick ^a  

^a WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CD4 ANTIGEN; CD59 ANTIGEN; CD8 ANTIGEN; DECAY ACCELERATING FACTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN CELL; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, CD; ANTIGENS, NEOPLASM; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; GLYCOPROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0029670929     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.3.325     Document Type: Article

References (27)

1. Hale, G., Xia, M.-Q., Tighe, H. P., Dyer, M. S. J and Waldmann, H. 1990 The CAMPATH-1 antigen (CDw52). Tissue Antigens 35.118.
2. Bindon, C. I , Hale, G. and Waldmann, H. 1988. Importance of antigen specificity for complement mediated lysis by monoclonal antibodies. Eur J Immunol. 18:1507.
3. Crowe, J. S., Hall, V., Smith, M. A., Cooper, H J. and Tite, J. P. 1992 Humanised monoclonal antibody Campath-1H: myeloma cell expression of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese Hamster Ovary derived material Clin. Exp. Immunol. 87:105.
4. Xia, M.-Q., Tone, M., Packman, L., Hale, G and Waldmann, H 1991. Characterisation of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone. Eur J. Immunol 21:1677.
5. Xia, M.-Q., Hale, Q., Lifely, M. R., Ferguson, M., Campbell, D., Packman, L. and Waldmann, H. 1993. Structure of the Campath-1H, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for comptement lysis. Biochem. J. 293:633.
6. Hale, G. and Waldmann, H. 1994. CAMPATH-1 monoclonal antibodies in bone marrow transplantation. J. Hematother 3:15.
7. Rowan, W. C., Hale, G., Tite, J. P. and Brett, S. J. 1995 Cross-linking of the CAMRATH-1 antigen (CD52) triggers activation of normal human T lymphocytes Int. Immunol. 7:69.
8. Dyer, M. J. S., Hale, G., Hayhoe, F G. J and Waldmann, H. 1988. Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. Blood 73:1431.
9. Riechmann, L., Clark, M. R., Waldmann, H. and Winter, G. 1988. Reshaping human antibodies for therapy Nature 332:323.
10. Isaacs, J. D., Watts, R. A., Hazelman, B. L., Hale, G., Keogan, M T., Cobbold, S. P. and Waldmann, H. 1992. Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet 340:748.
11. Paulus, H. E , Egger, M. J , Ward, J R., Williams, H J. and the Cooperative Systematic Studies of Rheumatic Diseases Group. 1990. Analysis of improvement in individual rheumatic arthritis patients treated with disease-modifying anti-rheumatic drugs based on the findings in patients treated with placebo. Arthritis Rheum. 33:477.
12. Gray, D. 1992. Life span of immune cells and molecules. In Roitt, I. M and Delves, P. J., eds. Encyclopedia of Immunology, p. 977. Academic Press, London
13. Poynton, C H., Shaw, P J and Barrett, A. J 1986. Leukaemic relapse associated with phenotypic change after CAMPATH-1 purged autologous bone marrow transplantation (letter). Lancet 1.162.
14. Bunjes, D , Theobald, M., Wiesneth, M M., Schrezenmeier, H., Hoffmann, T., Hertenstein, B., Arnold, R. and Heimpel, H. 1993 Graft rejection by a population of primed CDw52 negative host T cells after in vivo/ex vivo T-depleted bone marrow transplantation Bone Marrow Transplant. 12.209.
15. Hertenstein, B., Bunjes, D., Schrezenmeier, H., Wagner, B., Duncker, C , Arnold, R. and Heimpel, H 1995. Emergence of CD52 negative, phosphatidylinositol (PIG)-anchor deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma Blood in press.
16. Stevens, V. L. and Raetzm C. R 1991 Defective glycosyl phosphatidylinositol biosynthesis in extracts of three Thy-1 negative lymphoma cell mutants. J. Biol. Chem. 266:12119.
17. Sugiyama, E., DeGasperi, R., Urakaze, M., Chang, H. M., Thomas, L. I., Hyman, R., Warren, C. D. and Yen, E T. H 1991. Identification of defects in glycophosphatidylinositol anchor biosynthesis in the Thy-1 expression mutants. J Biol. Chem. 266:12119.
18. Schubert, J., Ostendorf, T. and Schmidt, R E. 1994. Biology of GPI-anchor structures and pathogenesis of paroxysmal nocturnal hemoglobinuria Immunol. Today 15:299.
19. Schubert, J., Schmidt, R. E. and Medof, M. E 1993 Regulation of glycoinositol phospholipid anchor assembly in human lymphocytes. J. Biol. Chem. 268.6281.
20. Armstrong, C., Schubert, J., Ueda, E., Knaz, J. J., Gelpern, D , Hirose, S., Silber, R., Hollan, S , Schmidt, R. E. and Medof, M. E 1992 Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1-murine lymphoma mutants 1992. J. Biol. Chem. 267.25347
21. Miyata, T., Takeda, J., Iida, Y., Yamada, N., Inoue, N., Takahashi, M., Maeda, K., Kitani, T. and Kinoshita, T. 1993. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 259:1318.
22. Takeda, J., Miyata, T., Kawagoe, K., Iida, Y., Endo, Y , Fujita, T , Takahashi, M., Kitani, T. and Kinoshita, T. 1993 Deficiency of the GPI-anchor caused by somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703
23. Bessler, M., Hillman, P , Longo, L., Luzzzatto, L and Mason, P. J 1994. Genomic organisation of the X-linked gene (PIG-A) that is mutated in paroxysmal nocturnal hemoglobinurea and of a related pseudogene mapped to 12q21. Hum. Mol Genet. 3.751.
24. Gilleece, M H and Dexter, T. M 1993 Effect of Campath-1H antibody on human hematopoietic progenitors in vitro. Blood 82:807.
25. Davis, L S., Patel, S S , Atkinson, J P. and Lipsky, P. E 1988. Decay-accelerating factor functions as a signal transducing molecule for human T cells J Immunol 141.2246
26. Korty, P E , Brando, C and Shevach, E. M. 1991 CD59 functions as a signal transducing molecule for human T cell activation. J Immunol 146:4092.
27. Thomas L. J., DeGasperi, R., Sugiyama, E., Chang, H.-M , Beck P J., Orlean, P , Urakaze, M , Kamitan, T., Sambrook, J. F., Warren, C. D and Yeh, E. T H 1991. Functional analysis of T cell mutants defective in the biosynthesis of glycosylphosphatidylinositol anchor. J. Biol Chem. 266:23175.